A Survey to Collect Treatment Experience Feedback From Patients, Physicians, Nurses and Carers After Switching to Paliperidone Palmitate 3-monthly

NCT03809325 · clinicaltrials.gov ↗

COMPLETED

Status

225

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Paliperidone Palmitate 3-Month Formulation (PP3M)

Sponsor

Janssen-Cilag International NV